These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

493 related items for PubMed ID: 31766991

  • 1. CYR61, a potential biomarker of tumor inflammatory response in epithelial ovarian cancer microenvironment of tumor progress.
    Shi J, Huo R, Li N, Li H, Zhai T, Li H, Shen B, Ye J, Fu R, Di W.
    BMC Cancer; 2019 Nov 25; 19(1):1140. PubMed ID: 31766991
    [Abstract] [Full Text] [Related]

  • 2. Inflammation-regulating factors in ascites as predictive biomarkers of drug resistance and progression-free survival in serous epithelial ovarian cancers.
    Lane D, Matte I, Garde-Granger P, Laplante C, Carignan A, Rancourt C, Piché A.
    BMC Cancer; 2015 Jul 01; 15():492. PubMed ID: 26122176
    [Abstract] [Full Text] [Related]

  • 3. Validity and prognostic significance of sperm protein 17 as a tumor biomarker for epithelial ovarian cancer: a retrospective study.
    Brunette LL, Mhawech-Fauceglia PY, Ji L, Skeate JG, Brand HE, Lawrenson K, Walia S, Chiriva-Internati M, Groshen S, Roman LD, Kast WM, Da Silva DM.
    BMC Cancer; 2018 Oct 11; 18(1):970. PubMed ID: 30309325
    [Abstract] [Full Text] [Related]

  • 4. Correlation of CD44v6 expression with ovarian cancer progression and recurrence.
    Shi J, Zhou Z, Di W, Li N.
    BMC Cancer; 2013 Apr 08; 13():182. PubMed ID: 23565736
    [Abstract] [Full Text] [Related]

  • 5. [Expression and significance of PD-1 and PD-L1 in the specimens of epithelial ovarian cancer].
    Ju C, Gao JC, Zhang PX, Zhang KN, Yang S, Kang TJ, Zhao HZ, Qi WJ, Zhang QP, Kong FD, Guan HW, Shi H.
    Zhonghua Fu Chan Ke Za Zhi; 2020 Aug 25; 55(8):529-534. PubMed ID: 32854477
    [Abstract] [Full Text] [Related]

  • 6. Cysteine-rich, angiogenic inducer, 61 expression in patients with ovarian epithelial carcinoma.
    Lin Y, Xu T, Tian G, Cui M.
    J Int Med Res; 2014 Apr 25; 42(2):300-6. PubMed ID: 24595148
    [Abstract] [Full Text] [Related]

  • 7. Prognostic Significance of Increased Expression of Annexin A10 (ANXA10) in Serous Epithelial Ovarian Cancer.
    Wang J, Zhao S, Wang F, Wang J, Zhang Y.
    Med Sci Monit; 2019 Jul 31; 25():5666-5673. PubMed ID: 31363077
    [Abstract] [Full Text] [Related]

  • 8. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
    Tassi RA, Todeschini P, Siegel ER, Calza S, Cappella P, Ardighieri L, Cadei M, Bugatti M, Romani C, Bandiera E, Zanotti L, Tassone L, Guarino D, Santonocito C, Capoluongo ED, Beltrame L, Erba E, Marchini S, D'Incalci M, Donzelli C, Santin AD, Pecorelli S, Sartori E, Bignotti E, Odicino F, Ravaggi A.
    J Exp Clin Cancer Res; 2017 May 08; 36(1):63. PubMed ID: 28482906
    [Abstract] [Full Text] [Related]

  • 9. Elevated growth differentiation factor 15 expression predicts poor prognosis in epithelial ovarian cancer patients.
    Zhang Y, Hua W, Niu LC, Li SM, Wang YM, Shang L, Zhang C, Li WN, Wang R, Chen BL, Xin XY, Zhang YQ, Wang J.
    Tumour Biol; 2016 Jul 08; 37(7):9423-31. PubMed ID: 26781874
    [Abstract] [Full Text] [Related]

  • 10. Natural Killer Cells Response to IL-2 Stimulation Is Distinct between Ascites with the Presence or Absence of Malignant Cells in Ovarian Cancer Patients.
    da Silva RF, Yoshida A, Cardozo DM, Jales RM, Paust S, Derchain S, Guimarães F.
    Int J Mol Sci; 2017 May 17; 18(5):. PubMed ID: 28513532
    [Abstract] [Full Text] [Related]

  • 11. [Relationship between interleukin-10 level in ascites of patients with primary ovarian epithelial carcinoma and immune defect in peritoneal cavity].
    Zhou JW, Cheng Q, Xie X, Chen HZ, Ye DF, Lu WG.
    Ai Zheng; 2004 May 17; 23(5):573-6. PubMed ID: 15142457
    [Abstract] [Full Text] [Related]

  • 12. YKL40/Integrin β4 Axis Induced by the Interaction between Cancer Cells and Tumor-Associated Macrophages Is Involved in the Progression of High-Grade Serous Ovarian Carcinoma.
    Yamanaka K, Koma YI, Urakami S, Takahashi R, Nagamata S, Omori M, Torigoe R, Yokoo H, Nakanishi T, Ishihara N, Tsukamoto S, Kodama T, Nishio M, Shigeoka M, Yokozaki H, Terai Y.
    Int J Mol Sci; 2024 Oct 01; 25(19):. PubMed ID: 39408927
    [Abstract] [Full Text] [Related]

  • 13. [Serum level and expression of vascular epithelial growth factor in ovarian epithelial carcinoma].
    Sun LX, Wu Y, Han HQ, Wang QH.
    Ai Zheng; 2003 Jan 01; 22(1):58-61. PubMed ID: 12561438
    [Abstract] [Full Text] [Related]

  • 14. Defective expression of Protein 4.1N is correlated to tumor progression, aggressive behaviors and chemotherapy resistance in epithelial ovarian cancer.
    Xi C, Ren C, Hu A, Lin J, Yao Q, Wang Y, Gao Z, An X, Liu C.
    Gynecol Oncol; 2013 Dec 01; 131(3):764-71. PubMed ID: 23994105
    [Abstract] [Full Text] [Related]

  • 15. Interleukin-8 and vascular endothelial growth factor mRNA and protein levels are down-regulated in ovarian carcinoma cells in serous effusions.
    Davidson B, Reich R, Kopolovic J, Berner A, Nesland JM, Kristensen GB, Tropé CG, Bryne M, Risberg B, van de Putte G, Goldberg I.
    Clin Exp Metastasis; 2002 Dec 01; 19(2):135-44. PubMed ID: 11964077
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The inflammatory microenvironment in epithelial ovarian cancer: a role for TLR4 and MyD88 and related proteins.
    Li Z, Block MS, Vierkant RA, Fogarty ZC, Winham SJ, Visscher DW, Kalli KR, Wang C, Goode EL.
    Tumour Biol; 2016 Oct 01; 37(10):13279-13286. PubMed ID: 27460076
    [Abstract] [Full Text] [Related]

  • 18. Cytokine profiling of ascites at primary surgery identifies an interaction of tumor necrosis factor-α and interleukin-6 in predicting reduced progression-free survival in epithelial ovarian cancer.
    Kolomeyevskaya N, Eng KH, Khan AN, Grzankowski KS, Singel KL, Moysich K, Segal BH.
    Gynecol Oncol; 2015 Aug 01; 138(2):352-7. PubMed ID: 26001328
    [Abstract] [Full Text] [Related]

  • 19. Expression of Lysine-specific demethylase 1 in human epithelial ovarian cancer.
    Chen C, Ge J, Lu Q, Ping G, Yang C, Fang X.
    J Ovarian Res; 2015 May 09; 8():28. PubMed ID: 25956476
    [Abstract] [Full Text] [Related]

  • 20. Oxytocin in the tumor microenvironment is associated with lower inflammation and longer survival in advanced epithelial ovarian cancer patients.
    Cuneo MG, Szeto A, Schrepf A, Kinner EM, Schachner BI, Ahmed R, Thaker PH, Goodheart M, Bender D, Cole SW, McCabe PM, Sood AK, Lutgendorf SK, Mendez AJ.
    Psychoneuroendocrinology; 2019 Aug 09; 106():244-251. PubMed ID: 31005045
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.